Gene expression profile of human adenocarcinoma by cDNA microarray and clustering

Chinese Journal of Medical Genetics

Volumn 21, Issue 2, 2004, Pages 110-115

  Shao, Yong ^a   Yang, Shao Bo ^a   Wang, Meng Wei ^a   Wu, Ben Yan ^a   You, Wei Di ^a   Li, Hong ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

CDNA microarray; Gastric adenocarcinoma; Gene expression profile

Indexed keywords

GROWTH FACTOR;

ADENOCARCINOMA; ADULT; ADVANCED CANCER; ARTICLE; CELL ADHESION; CLINICAL ARTICLE; CLUSTER ANALYSIS; DNA MICROARRAY; DNA PROBE; EXTRACELLULAR MATRIX; FEMALE; GENE CLUSTER; GENE EXPRESSION REGULATION; GENETIC ANALYSIS; GENETIC HETEROGENEITY; HUMAN; MALE; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCANNING ELECTRON MICROSCOPY;

ADENOCARCINOMA; ADULT; AGED; CLUSTER ANALYSIS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; STOMACH NEOPLASMS;

EID: 1942536152     PISSN: 10039406     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Wan J, Zhang ZQ, Zhu C, et al. Evaluation of the clinical screening and the follow-up for early gastric cancer by gastroscopy in the elderly. Chin J Geriatr, 2001, 20: 103-104.
2. Quackenbush J. Microarray data normalization and transformation. Nat Genetics, 2002, 32 (suppl): 496-501.
3. Eisen MB, Spellman PT, Brown PO, et al. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A, 1998, 95: 14863-14868.
4. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A, 2001, 98: 5116-5121.
5. Xiao Y, Segal MR, Rabert D, et al. Assessment of differential gene expression in human peripheral nerve injury. BMC Genomics, 2002, 3: 28.
6. Hippo Y, Taniguchi H, Tsutsumi S, et al. Global gene expression analysis of gastric cancer by oligonucleotide microarrays. Cancer Res, 2002, 62: 233-240.
7. Sorlie T, Perou CM, Tibshirani R, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A, 2001, 98: 10869-10874.
8. Moschos SJ, Mantzoros CS. The role of the IGF system in cancer: from basic to clinical studies and clinical applications. Oncology, 2002, 63: 317-332.
9. Wu MS, Wang HP, Lin CC, et al. Loss of imprinting and overexpression of IGF2 gene in gastric adenocarcinoma. Cancer Lett, 1997, 120: 9-14.
10. Yi HK, Hwang PH, Yang DH, et al. Expression of the insulin-like growth factors (IGFs) and the IGF-binding proteins (IGFBPs) in human gastric cancer cells. Eur J Cancer, 2001, 37: 2257-2263.
11. Kipreos ET, Pagano M. The F-box protein family: Genome Biol, 2000, 1: REVIEWS3002.
12. Gstaiger M, Jordan R, Lim M, et al. Skp2 is oncogenic and overexpressed in human cancers. Proc Natl Acad Sci U S A, 2001, 98: 5043-5048.
13. Hong SI, Park IC, Hong WS, et al. Overexpression of tissue inhibitors of metalloproteinase-1 and -2 in the stroma of gastric cancer. J Korean Med Sci, 1996, 11: 474-479.
14. Yoshikawa T, Tsuburaya A, Kobayashi O, et al. Intratumoral concentrations of tissue inhibitor of matrix metalloproteinase 1 in patients with gastric carcinoma a new biomarker for invasion and its impact on survival. Cancer, 2001, 91: 1739-1744.
15. Li XY, Hu JL. CD44 with digestive tumour and metastasis. Chin J Digest, 1999, 19: 196-197.
16. Sun XJ, Sun KL, Fu H, et al. Expression of S100A4 and nm23H1 in gastric cancer and its relationship to lymph node metastasis. Natl Med J China, 2001, 81: 59-60.
17. Komatsu K, Murata K, Kameyama M, et al. Expression of S100A6 and S100A4 in matched samples of human colorectal mucosa, primary colorectal adenocarcinomas and liver metastases. Oncology, 2002, 63: 192-200.
18. Plebani M, Herszenyi L, Carraro P, et al. Urokinase-type plasminogen activator receptor in gastric cancer: tissue expression and prognostic role. Clin Exp Metastasis, 1997, 15: 418-425.
19. Okusa Y, Ichikura T, Mochizuki H, et al. Urokinase type plasminogen activator and its receptor regulate the invasive potential of gastric cancer cell lines. Int J Oncol, 2000, 17: 1001-1005.
20. Joo YE, Seo KS, Kim HS, et al. Expression of tissue inhibitors of metalloproteinases (TIMPs) in gastric cancer. Dig Dis Sci, 2000, 45: 114-121.
21. Murray GI, Duncan ME, Arbuckle E, et al. Matrix metalloproteinases and their inhibitors in gastric cancer. Gut, 1998, 43: 791-797.
22. Oesterreich S, Lee AV, Sullivan TM, et al. Novel nuclear matrix protein HET binds to and influences activity of the HSP27 promoter in human breast cancer cells. J Cell Biochem, 1997, 67: 275-286.
23. Townson SM, Sullivan T, Zhang Q, et al. HET/SAF-B overexpression causes growth arrest and multinuclearity and is associated with aneuploidy in human breast cancer. Clin Cancer Res, 2000, 6: 3788-3796.
24. Ebert MP, Gunther T, Hoffmann J, et al. Expression of metallothionein II in intestinal metaplasia, dysplasia, and gastric cancer. Cancer Res, 2000, 60: 1995-2001.
25. Janssen AM, van Duijn W, Oostendorp-van de Ruit MM, et al. Metallothionein in human gastrointestinal cancer. J Pathol, 2000, 192: 293-300.
26. Tuccari G, Giuffre G, Arena F, et al. Immunohistochemical detection of metallothionein in carcinomatous and normal human gastric mucosa. Histol Histopathol, 2000, 15: 1035-1041.
27. Hu JB, Deng YC, Zheng S. Expression of a novel immunoglobulin gene SNC73 in human cancer and its significance. Chin J Oncol, 2002, 24: 38-40.